Estonia - estoniană - Ravimiamet

norpharm regulatory services ltd - paratsetamool+feniramiin+askorbiinhape - suukaudse lahuse graanulid - 500mg+25mg+200mg 6tk; 500mg+25mg+200mg 8tk

Estonia - estoniană - Ravimiamet

krka, d.d., novo mesto - tsiprofloksatsiin - õhukese polümeerikattega tablett - 250mg 10tk

Estonia - estoniană - Ravimiamet

krka, d.d., novo mesto - tsiprofloksatsiin - õhukese polümeerikattega tablett - 750mg 10tk

Estonia - estoniană - Ravimiamet

caduceus pharma ltd. - prometasiin - õhukese polümeerikattega tablett - 50mg 5tk; 50mg 20tk; 50mg 10tk; 50mg 16tk; 50mg 30tk; 50mg 14tk; 50mg 8tk; 50mg 56tk

Estonia - estoniană - Ravimiamet

krka, d.d., novo mesto - tsiprofloksatsiin - infusioonilahus - 2mg 1ml 100ml 1tk; 2mg 1ml 200ml 1tk; 2mg 1ml 50ml 1tk

Estonia - estoniană - Ravimiamet

teva b.v. - darunaviir - õhukese polümeerikattega tablett - 800mg 90tk; 800mg 100tk; 800mg 10tk

Estonia - estoniană - Ravimiamet

krka, d.d., novo mesto - tsiprofloksatsiin - infusioonilahuse kontsentraat - 10mg 1ml 10ml 5tk

Estonia - estoniană - Ravimiamet

krka, d.d., novo mesto - tsiprofloksatsiin - õhukese polümeerikattega tablett - 500mg 10tk

Uniunea Europeană - estoniană - EMA (European Medicines Agency)

secura bio limited - duvelisib - leukemia, lymphocytic, chronic, b-cell; lymphoma, follicular - antineoplastilised ained - copiktra monotherapy is indicated for the treatment of adult patients with: relapsed or refractory chronic lymphocytic leukaemia (cll) after at least two prior therapies.  follicular lymphoma (fl) that is refractory to at least two prior  systemic therapies.

Uniunea Europeană - estoniană - EMA (European Medicines Agency)

vifor fresenius medical care renal pharma france - difelikefalin - pruritus - kõik muud ravitoimingud - kapruvia is indicated for the treatment of moderate-to-severe pruritus associated with chronic kidney disease in adult patients on haemodialysis (see section 5.